In TIMER (Figure 8B), the high-risk group exhibited elevated expression levels of anti-tumor immune cells, encompassing CD8+ T cells, CD4+ T cells, B cells, macrophages, and dendritic cells. The gene discussed is CD8A; the disease is neoplasm.